Related references
Note: Only part of the references are listed.Plasminogen Activator Inhibitor-1 (PAI-1): A Key Factor Linking Fibrinolysis and Age-Related Subclinical and Clinical Conditions
Matteo Cesari et al.
CARDIOVASCULAR THERAPEUTICS (2010)
MiR423-5p As a Circulating Biomarker for Heart Failure
Anke J. Tijsen et al.
CIRCULATION RESEARCH (2010)
Association of Left Atrial Endothelin-1 With Atrial Rhythm, Size, and Fibrosis in Patients With Structural Heart Disease
Fadia Mayyas et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2010)
Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
A. John Camm et al.
EUROPEAN HEART JOURNAL (2010)
N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation The Cardiovascular Health Study
Kristen K. Patton et al.
CIRCULATION (2009)
Will we be able to predict in which atrial fibrillation patients a rhythm control strategy will be successful?
Marcelle D. Smit et al.
EUROPACE (2009)
Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β
Rudolf Jarai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Differential behaviors of atrial versus ventricular fibroblasts - A potential role for platelet-derived growth factor in atrial-ventricular remodeling differences
Brett Burstein et al.
CIRCULATION (2008)
Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time
Sandra Buck et al.
EUROPACE (2008)
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation - A randomized trial
Sheba Ahmed et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
Francisco G. Cosio et al.
EUROPACE (2008)
A secretion trap screen in yeast identifies protease inhibitor 16 as a novel antihypertrophic protein secreted from the heart
Robert J. A. Frost et al.
CIRCULATION (2007)
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP
Michiel Rienstra et al.
EUROPACE (2006)
Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T
AH Maass et al.
CIRCULATION (2004)
Rational promoter selection for gene transfer into cardiac cells
A Maass et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Share Paper
